Use Options For A Chance To Buy CLDX At A 62% Discount
moreView todays social media effects on CLDXView the latest stocks trending across Twitter. Click to view dashboardSee who Celldex is hiring next, click here to view […]
CLDX
Celldex Presents CDX-1127 In Vitro Human Data Consistent With Strong Potency and Safety Profile at AACR 2013
[at noodls] – –Results Directly Complement Ongoing Clinical Development– NEEDHAM, Mass., April 8, 2013 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (Nasdaq:CLDX) today reported the results of an in vitro study analyzing … moreView todays social media effects on CLDXView the latest stocks trending across Twitter. Click to view dashboardSee who Celldex is hiring next, click here to view […]
Celldex Therapeutics Announces Upcoming Presentation at Leerink Swann Global Healthcare Conference 2013
[at noodls] – NEEDHAM, Mass., Feb. 11, 2013 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that Anthony Marucci, President and Chief Executive Officer, is scheduled to present a corporate … moreView todays social media effects on CLDXView the latest stocks trending across Twitter. Click to view dashboardSee who Celldex is hiring next, click here to view […]
Celldex Announces Upcoming Oral Presentation on CDX-301 at the American Society for Blood and Marrow Transplantation 2013 BMT Tandem Meetings
[at noodls] – NEEDHAM, Mass., Feb. 11, 2013 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (Nasdaq:CLDX) today announced that Michael Yellin, MD, Vice President of Clinical Science, will present final results from a … moreView todays social media effects on CLDXView the latest stocks trending across Twitter. Click to view dashboardSee who Celldex is hiring next, click here to view […]
Celldex Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
[at noodls] – NEEDHAM, Mass., Feb. 8, 2013 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (Nasdaq:CLDX) today announced that the underwriters of its previously announced public offering of common stock have exercised … moreView todays social media effects on CLDXView the latest stocks trending across Twitter. Click to view dashboardSee who Celldex is hiring next, click here to view […]
Celldex Announces Pricing of $90 Million Public Offering of Common Stock
[at noodls] – NEEDHAM, Mass., Feb. 5, 2013 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (Nasdaq:CLDX) today announced the pricing of an underwritten public offering of 12,000,000 shares of its common stock, offered … moreView todays social media effects on CLDXView the latest stocks trending across Twitter. Click to view dashboardSee who Celldex is hiring next, click here to view […]
Celldex Announces $75,000,000 Proposed Public Offering of Common Stock
[at noodls] – NEEDHAM, Mass., Feb. 4, 2013 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (Nasdaq:CLDX) today announced that it is offering $75,000,000 of its common stock in a proposed underwritten public offering. … moreView todays social media effects on CLDXView the latest stocks trending across Twitter. Click to view dashboardSee who Celldex is hiring next, click here to view […]
